Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

Pluristyx's iPSC platform provides therapeutic developers with a streamlined path from research to clinical application, offering high-quality, regulatory-compliant starting materials and advanced ...

Pipeline advancements and investment in innovation and disruptive technologies to help fuel sustainable, profitable growth for CSL's three businesses, CSL Behring, CSL Seqirus and CSL Vifor, in the ...

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

Gene therapies are unlocking new drug targets that were previously thought undruggable. Covering modalities like ASOs, siRNA, saRNA, mRNA, and ADARs, each with different mechanisms of action, gene ...

A study conducted by a multinational research group investigated the potential of audible sound waves (in the form of music, specifically Pink Floyd’s "Another Brick in the Wall, Part 1") in enhancing ...

COVID-19 mRNA-based vaccines seemingly boosted immunity in cancer patients, significantly prolonging their lives, new ...

The growing demand for gene therapy and mRNA vaccines is driving the need for highly purified plasmid DNA. Manufacturing companies are moving towards 'GMP' standards to meet clinical and commercial ...

Scientists have discovered the internal shape of tiny drug-delivery particles – called lipid nanoparticles – has a big impact on how well our cells absorb them, paving the way to more efficient ...

Voyager Therapeutics, Inc. has announced that it will present eight oral and poster presentations at the American Society of Gene & Cell Therapy's upcoming annual meeting, focusing on its innovative ...